Covid-19 Inquiry: Immunosuppression
To ask His Majesty's Government how the needs of the Clinically Extremely Vulnerable, as distinct from the disabled, will be addressed in the UK COVID-19 Inquiry.
Government answer
The UK COVID-19 Inquiry is independent of the Government. The process, procedure and timing of the Inquiry are matters for the Chair, Baroness Hallett.
On 16th January 2023 the Chair designated the group Clinically Vulnerable Families as a Core Participant for Module 3 of the Inquiry which covers healthcare systems in England, Wales, Scotland and Northern Ireland. It is for the Inquiry itself to provide any further detail on the important issue of how the needs of the Clinically Extremely Vulnerable will be addressed.
The Government is committed to learning from the Covid-19 Inquiry’s findings which will play a key role in informing planning and preparations for the future; it continues to work closely with the Inquiry.